HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louie Naumovski Selected Research

sapphyrin

1/2007Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expression.
11/2006Tumor localization and antitumor efficacy of novel sapphyrin compounds.
6/2005Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Louie Naumovski Research Topics

Disease

17Neoplasms (Cancer)
01/2021 - 06/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2017 - 09/2013
2Lymphoma (Lymphomas)
10/2009 - 06/2005
2Hematologic Neoplasms (Hematological Malignancy)
01/2007 - 12/2005
2Starvation
05/2003 - 06/2002
1Sarcoma (Soft Tissue Sarcoma)
01/2021
1Neutropenia
12/2020
1Nausea
12/2020
1Fatigue
12/2020
1Thrombocytopenia (Thrombopenia)
12/2020
1Pleural Effusion (Pleural Effusions)
12/2020
1Tics (Tic)
01/2018
1Oncogene Addiction
02/2016
1Melanoma (Melanoma, Malignant)
04/2010
1Breast Neoplasms (Breast Cancer)
04/2010
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2009
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2009
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2009
1Carcinogenesis
03/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2005
1Hypoxia (Hypoxemia)
12/2005
1Lung Neoplasms (Lung Cancer)
12/2005
1Leukemia
06/2005
1Fibrosarcoma
05/2003
1Glioblastoma (Glioblastoma Multiforme)
06/2002
1Brain Neoplasms (Brain Tumor)
06/2002

Drug/Important Bio-Agent (IBA)

5motexafin gadoliniumIBA
12/2009 - 12/2005
5Antineoplastic Agents (Antineoplastics)IBA
10/2009 - 06/2005
5Proteins (Proteins, Gene)FDA Link
03/2009 - 06/2002
4Immunoconjugates (Immunoconjugate)IBA
01/2021 - 02/2017
4PorphyrinsIBA
10/2009 - 05/2006
3sapphyrinIBA
01/2007 - 06/2005
2telisotuzumab vedotinIBA
11/2018 - 02/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 09/2013
2Pharmaceutical PreparationsIBA
01/2018 - 04/2010
2CaspasesIBA
10/2009 - 06/2005
2PCI 2050IBA
01/2007 - 11/2006
2PCI 2000IBA
11/2006 - 06/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2003 - 06/2002
1GemcitabineFDA Link
01/2021
1Leucine (L-Leucine)FDA Link
01/2021
1pyrrolo(2,1-c)(1,4)benzodiazepineIBA
12/2020
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2020
1Prolactin Receptors (Prolactin Receptor)IBA
12/2020
1delta proteinIBA
01/2018
1ABT-165IBA
01/2018
1Cytotoxins (Cytolysins)IBA
02/2017
1Monoclonal AntibodiesIBA
02/2016
1AntibodiesIBA
09/2013
1Glycoproteins (Glycoprotein)IBA
04/2010
1glembatumumab vedotinIBA
04/2010
1monomethyl auristatin EIBA
04/2010
1IgA receptor (protein B)IBA
04/2010
1Rituximab (Mabthera)FDA Link
10/2009
1ibritumomab tiuxetan (Zevalin)FDA Link
10/2009
1Biological ProductsIBA
01/2007
1Sulfhydryl Compounds (Thiols)IBA
01/2007
1Zinc AcetateFDA Link
12/2005
1ZincIBA
12/2005
1Transcription Factors (Transcription Factor)IBA
12/2005
1MetalsIBA
12/2005
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2005
1Annexin A5IBA
06/2005
1Cytochromes c (Cytochrome c)IBA
06/2005
1PCI 2010IBA
06/2005
1TunicamycinIBA
05/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2003
1Brefeldin AIBA
05/2003
1ThapsigarginIBA
05/2003
1RNA (Ribonucleic Acid)IBA
06/2002
1Complementary DNA (cDNA)IBA
06/2002

Therapy/Procedure

6Therapeutics
01/2021 - 06/2002
2Drug Therapy (Chemotherapy)
02/2017 - 06/2002
1Time-to-Treatment
10/2009